Sebastian Ueckert

Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial

Hiddo J.L. Heerspink, Arihiro Kiyosue, David C. Wheeler et al. · The Lancet · 2023 · 111 citations · Full text

Renal Function, Renal Disease, Phase 2B +7

PopED: An extended, parallelized, nonlinear mixed effects models optimal design tool

Joakim Nyberg, Sebastian Ueckert, Eric A. Strömberg et al. · Computer Methods and Programs in Biomedicine · 2012 · 82 citations

Design Space Exploration, Design Tool, Engineering +8

Modeling Composite Assessment Data Using Item Response Theory

Sebastian Ueckert · CPT Pharmacometrics & Systems Pharmacology · 2018 · 46 citations · Full text

Engineering, Composite Assessments, Psychiatry +11

Item Response Theory as an Efficient Tool to Describe a Heterogeneous Clinical Rating Scale in De Novo Idiopathic Parkinson’s Disease Patients

Simon Buatois, Sylvie Retout, Nicolas Frey et al. · Pharmaceutical Research · 2017 · 44 citations · Full text

Neuroimaging Biomarkers, Psychiatry, Item Response Theory +8

Comparison of Model Averaging and Model Selection in Dose Finding Trials Analyzed by Nonlinear Mixed Effect Models

Simon Buatois, Sebastian Ueckert, Nicolas Frey et al. · The AAPS Journal · 2018 · 36 citations · Full text

Precision Dosing, Treatment Effect, Biostatistics +8